SINGAPORE - Media OutReach Newswire - 7 May 2026 - Dr. Terence Tan, Medical Director of Halley Medical Aesthetics and Halley Body Slimming Clinic, shared his clinical insights on integrating Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) into everyday practice at the symposium “Optimising Longevity and Weight Management with GLP-1 RAs”. The event brought together approximately 80 general practitioners (GPs) and aesthetic doctors for a focused discussion on the evolving role of medical weight management in Singapore.
Dr. Terence Tan presenting at a symposium, sharing insights on medical weight management in Singapore and the use of GLP-1 receptor agonists (GLP-1 RAs), including patient selection and common clinical challenges.
The Growing Role of GLP-1 Therapies in Clinical Practice
This continuing medical education (CME) session addressed a clear shift in clinical practice, where more patients are actively seeking medical support for weight loss and management. They are increasingly arriving informed, often asking specifically about newer medications and expecting clear guidance on suitability and outcomes.
GLP-1 RAs, including semaglutide and tirzepatide, have contributed to this change. These medications work by influencing appetite and satiety, helping to reduce overall caloric intake. Semaglutide acts on GLP-1 receptors to regulate hunger, while tirzepatide targets both GLP-1 and GIP pathways, offering an additional mechanism that supports weight reduction and metabolic control.
As a result, consultations are becoming more complex. Patients may have expectations shaped by online information or anecdotal experiences, making it important for doctors to guide discussions based on clinical suitability rather than demand alone.
“This shift calls for a more structured and informed approach,” said Dr. Tan. “Doctors must take a more active role in assessing patients, setting expectations, and ensuring that treatment is used appropriately as part of a broader weight management strategy.”
Looking Beyond BMI When Determining Treatment Suitability
Dr. Tan emphasised that successful use of GLP-1 RAs begins with careful patient selection. Clinical guidelines typically recommend treatment for individuals with a body mass index (BMI) of 30 kg/m² or higher, or 27 kg/m² with at least one weight-related condition such as hypertension or dyslipidaemia.
However, beyond these criteria, real-world decision-making often requires a more nuanced approach. Doctors should work to assess each patient’s broader context, including their occupation, psychological readiness, and ability to commit to follow-up. For example, many patients in GP settings are working adults who are motivated to lose weight but may struggle with consistency. For this group, medical support can offer a more practical pathway than lifestyle changes or advice.
A Structured Approach to GLP-1 Therapy in General Practice
A key theme of Dr. Tan’s presentation was that GLP-1 therapy should not be treated as a one-off prescription, but as part of a structured care process. He outlined the importance of setting clear goals from the outset, guiding patients towards gradual and realistic weight loss. Early targets may involve a reduction of 1.5 to 2 kilograms per month, followed by a slower and more sustainable pace.
Weight loss injections are introduced gradually, with doctors adjusting the dose over time while monitoring patients' responses. During this period, patients may experience side effects such as nausea or fatigue, particularly in the early stages, which are reviewed during follow-up visits. Clinics should also schedule monthly reviews at the start, before spacing them out based on progress.
Within the clinic, staff play an active role in supporting treatment. Beyond administrative duties, they guide patients through injection techniques, provide counselling, and reinforce key instructions throughout the process. They should also share educational materials and structured programmes to help patients stay more consistent and engaged with treatment.
Together, these elements form a coordinated care pathway in which doctors actively guide patients through each stage of treatment rather than relying solely on medication.
Reinforcing Lifestyle and Behavioural Change Alongside Treatment
While GLP-1 RAs support weight loss, Dr. Tan emphasised that they do not replace lifestyle change. Dietary adjustments, including reduced-calorie approaches and structured eating patterns such as time-restricted eating, remain important. Physical activity also plays a key role, increasing energy expenditure and maintaining a caloric deficit, thereby supporting sustained weight loss over time.
He also highlighted the importance of behavioural factors. Encouraging patient commitment and involving family or social support systems can strengthen adherence and improve long-term outcomes. Weight management, he noted, requires attention to both biological and behavioural factors.
Maintaining Long-Term Weight Loss Outcomes
Weight management does not end once initial targets are achieved. Dr. Tan noted that maintaining weight loss can be challenging, particularly for patients who have experienced significant reductions. While motivation plays a role, physiological factors such as appetite regulation can make long-term maintenance difficult.
Patients who adopt consistent lifestyle changes, including regular physical activity and more mindful food choices, may sustain their results over time. For others, ongoing or adjusted treatment may be considered. Options can include continuing medication, reducing the dosage, or using treatment periodically, depending on individual needs and preferences.
At the same time, doctors should inform their patients about the possibility of a weight-loss plateau, a common and expected phase of treatment. Even in such cases, continued management may still provide meaningful health benefits.
Addressing Real-World Challenges in Clinical Implementation
Dr. Tan also addressed practical challenges in adopting GLP-1 RAs. Cost remains a key consideration, particularly in the absence of broader subsidies. However, as other types of weight-loss medication become more widely available and competition grows, GLP-1 therapies may gradually become more affordable.
Patient awareness is another factor. Some individuals may not be familiar with these treatments, while others may have concerns about side effects. Dr. Tan emphasised that these concerns are best addressed through doctor-led consultations, where treatment decisions are guided by an individual assessment of benefits and risks.
Weight management is also influenced by underlying biological factors. Differences in appetite regulation and satiety can affect how individuals respond to food intake, which partly explains why maintaining weight loss can be challenging. According to Dr. Tan, some patients are able to sustain results through increased physical activity and more mindful eating, while others may find it difficult to maintain their weight after stopping medication.
A Shift Towards More Comprehensive, Long-Term Weight Management
As GLP-1 therapies become more widely used in Singapore, weight management is increasingly being approached as an ongoing clinical discipline rather than a short-term intervention. This shift places greater emphasis on continuity of care, patient education, and the doctors' role in guiding treatment decisions over time.
“GLP-1 therapies are changing how patients approach weight loss, but medication alone is not the solution,” said Dr. Tan. “As doctors, it is our responsibility to ensure that patients are properly assessed, supported, and followed up throughout their weight management journey.”
To learn more about Halley Body Slimming Clinic’s approach to weight management, visit their website.
Hashtag: #HalleyBodySlimmingClinic #GLP1RA #Glucagon-LikePeptide-1ReceptorAgonists #weightlossmanagement
The issuer is solely responsible for the content of this announcement.
About Halley Body Slimming Clinic
Halley Body Slimming Clinic is a Singapore-based clinic offering doctor-led treatments focused on weight loss, body contouring, skin firming, and more. The clinic takes a consultative approach, where each patient undergoes a clinical assessment before receiving a personalised treatment plan tailored to their goals and needs. Services include prescription weight-loss medications, along with non-invasive fat-reduction and body-contouring treatments using CoolSculpting Elite and Vanquish to address specific areas. By combining medical interventions with regular follow-up and patient education, the clinic supports individuals through different phases of their weight management journey.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
New report finds the real source of CMO complexity is not external but organisational, reframing modern marketing leadership as, at its core, a decision problem
HONG KONG SAR - Media OutReach Newswire - 7 May 2026 - The Marketing Society, in partnership with marketing effectiveness consultancy Ekimetrics, today launches The CMO Tension Report, a new piece of research drawing on conversations with 14 Chief Marketing Officers (CMOs) and business leaders across Asia-Pacific.
The Marketing Society and Ekimetrics Launch ‘The CMO Tension Report’ The report surfaces something that many marketing leaders are already living but rarely see reflected back clearly: that the complexity facing CMOs today is not simply external. It is organisational and, at its core, a decision problem.
Fragmented structures, misaligned KPIs, and unclear ownership across functions are making it increasingly difficult for senior marketers to make confident, cohesive decisions. CMOs have more data and tools at their disposal than ever before, but the challenge now is clarity. This gap in clarity widens the distance between what businesses are ambitious to achieve and what marketing leaders can realistically deliver.
What makes the report timely is the consistency of what it found. 14 senior leaders across different sectors and markets described a remarkably similar set of pressures, not as isolated trends, but as forces converging at once: the tension between short-term ROI and long-term brand value; the friction created by fragmented measurement and ownership across the business; the role of AI, which leaders broadly acknowledge improves efficiency but does not resolve how decisions are made or who is accountable for them.
Sophie Devonshire, CEO of The Marketing Society, said "At The Marketing Society, we've long held that marketing is the key driver of growth in business. And yet, when we talk to our members across the world, we keep hearing the same thing, that the biggest tension CMOs face is bridging the gap between the business's ambition to grow and the reality of delivering that growth. That tension plays out across multiple dimensions simultaneously — AI, creativity, measurement, ownership, short-term versus long-term — and in a region as vast and varied as APAC, every one of those dimensions is amplified. We brought together 14 marketers from 13 organisations to share how they are navigating this in their daily lives. What came through clearly is that the fundamentals of marketing remain constant. What is changing, and will keep changing, is how we apply them. This report exists to help the marketing community learn how to do exactly that."
Olivier Kuziner, Managing Partner APAC at Ekimetrics, said "At Ekimetrics, we believe the defining leadership challenge for modern marketing is orchestrating short-term and long-term performance together through better decision making. That belief is what drew us to this research, and what the report confirms. The CMOs we spoke to across APAC are operating in an environment where data abundance, channel fragmentation, and performance culture have accelerated decision cycles, while shrinking patience for long-term returns. The risk, and we see it consistently, is organisations mistaking efficiency for effectiveness, and optimisation for transformation. Value comes from fixing the system; the measurement frameworks, the shared definitions of success, the cross-functional alignment. This report makes that case through the voices of leaders who are working through it in real time."
Underlying all of it is a broader shift in what is expected of marketing, from execution to strategic growth engine. The report examines not just the tensions CMOs are navigating, but what organisations need to change: clearer decision-making frameworks, better cross-functional alignment, and a shared understanding of how marketing creates value over time.
The CMO Tension Report is available to view and download at https://heyzine.com/flip-book/cmotensionreport.html.
Hashtag: #TheMarketingSociety #Ekimetrics #CMOTensionReport
https://www.marketingsociety.com
The issuer is solely responsible for the content of this announcement.
About The Marketing Society
www.marketingsociety.com
The Marketing Society is the influential global community that expands perspectives on what marketers can achieve, founded in 1959, in a pub as a not-for-profit organisation. Since then, we have grown to become a highly influential community of marketing leaders around the world, with hubs in England (HQ), Scotland, Hong Kong, Singapore, United Arab Emirates and New York.
Connecting the brightest voices in marketing to unlock the best of each other through accelerated growth, actionable inspiration, and influential connections.
At a time when marketers have never been more crucial as the people-centric growth engine of business, we recognise their essential role amid complexity and change. By bringing together marketing's brightest voices, we help them do well, do good and feel good whilst collectively elevating marketing's influence and impact. We are for marketers who mean business.
That's why The Marketing Society exists, to unite global change leaders to accelerate responsible business growth. Together, we achieve more.
Through the connections of our 3,000+ Membership community, a world-class programme of events, ground-breaking professional development programmes, prestigious Awards scheme, publications, and insightful content, we help empower our members to lead success in their organisations and add value to customers and society, leading the conversation in businesses and the industry.
HONG KONG SAR - Media OutReach Newswire - 7 May 2026 - The Marketing Society, in partnership with marketing effectiveness consultancy Ekimetrics, today launches The CMO Tension Report, a new piece of research drawing on conversations with 14 Chief Marketing Officers (CMOs) and business leaders across Asia-Pacific.
The Marketing Society and Ekimetrics Launch ‘The CMO Tension Report’
The report surfaces something that many marketing leaders are already living but rarely see reflected back clearly: that the complexity facing CMOs today is not simply external. It is organisational and, at its core, a decision problem.
Fragmented structures, misaligned KPIs, and unclear ownership across functions are making it increasingly difficult for senior marketers to make confident, cohesive decisions. CMOs have more data and tools at their disposal than ever before, but the challenge now is clarity. This gap in clarity widens the distance between what businesses are ambitious to achieve and what marketing leaders can realistically deliver.
What makes the report timely is the consistency of what it found. 14 senior leaders across different sectors and markets described a remarkably similar set of pressures, not as isolated trends, but as forces converging at once: the tension between short-term ROI and long-term brand value; the friction created by fragmented measurement and ownership across the business; the role of AI, which leaders broadly acknowledge improves efficiency but does not resolve how decisions are made or who is accountable for them.
Sophie Devonshire, CEO of The Marketing Society, said "At The Marketing Society, we've long held that marketing is the key driver of growth in business. And yet, when we talk to our members across the world, we keep hearing the same thing, that the biggest tension CMOs face is bridging the gap between the business's ambition to grow and the reality of delivering that growth. That tension plays out across multiple dimensions simultaneously — AI, creativity, measurement, ownership, short-term versus long-term — and in a region as vast and varied as APAC, every one of those dimensions is amplified. We brought together 14 marketers from 13 organisations to share how they are navigating this in their daily lives. What came through clearly is that the fundamentals of marketing remain constant. What is changing, and will keep changing, is how we apply them. This report exists to help the marketing community learn how to do exactly that."
Olivier Kuziner, Managing Partner APAC at Ekimetrics, said "At Ekimetrics, we believe the defining leadership challenge for modern marketing is orchestrating short-term and long-term performance together through better decision making. That belief is what drew us to this research, and what the report confirms. The CMOs we spoke to across APAC are operating in an environment where data abundance, channel fragmentation, and performance culture have accelerated decision cycles, while shrinking patience for long-term returns. The risk, and we see it consistently, is organisations mistaking efficiency for effectiveness, and optimisation for transformation. Value comes from fixing the system; the measurement frameworks, the shared definitions of success, the cross-functional alignment. This report makes that case through the voices of leaders who are working through it in real time."
Underlying all of it is a broader shift in what is expected of marketing, from execution to strategic growth engine. The report examines not just the tensions CMOs are navigating, but what organisations need to change: clearer decision-making frameworks, better cross-functional alignment, and a shared understanding of how marketing creates value over time.
The CMO Tension Report is available to view and download at https://heyzine.com/flip-book/cmotensionreport.html.
Hashtag: #TheMarketingSociety #Ekimetrics #CMOTensionReport
https://www.marketingsociety.com
The issuer is solely responsible for the content of this announcement.
About The Marketing Society
www.marketingsociety.com
The Marketing Society is the influential global community that expands perspectives on what marketers can achieve, founded in 1959, in a pub as a not-for-profit organisation. Since then, we have grown to become a highly influential community of marketing leaders around the world, with hubs in England (HQ), Scotland, Hong Kong, Singapore, United Arab Emirates and New York.
Connecting the brightest voices in marketing to unlock the best of each other through accelerated growth, actionable inspiration, and influential connections.
At a time when marketers have never been more crucial as the people-centric growth engine of business, we recognise their essential role amid complexity and change. By bringing together marketing's brightest voices, we help them do well, do good and feel good whilst collectively elevating marketing's influence and impact. We are for marketers who mean business.
That's why The Marketing Society exists, to unite global change leaders to accelerate responsible business growth. Together, we achieve more.
Through the connections of our 3,000+ Membership community, a world-class programme of events, ground-breaking professional development programmes, prestigious Awards scheme, publications, and insightful content, we help empower our members to lead success in their organisations and add value to customers and society, leading the conversation in businesses and the industry.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
